Effect of melatonin on proliferative activity and apoptosis in spermatogenic cells in mouse under chemotherapy

Journal of Reproduction and Contraception

Volumn 21, Issue 2, 2010, Pages 79-94

  Ghasemi, Fahimeh Mohamad ^a   Faghani, Masoumeh ^a   Khajehjahromi, Sina ^b   Bahadori, Mohamadhadi ^a   Nasiri E, Ebrahim ^a   Hemadi, Masoud ^c  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Anatomy Department Faculty of Medicine   (Iran)

Author keywords

Apoptosis; Busulfan; Melatonin; Proliferative activity; Sperm parameters; Testis

Indexed keywords

ALCOHOL; BROXURIDINE; BUSULFAN; MELATONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL COUNT; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SPERMATOCYTE; SPERMATOZOON MOTILITY; SPERMATOZOON TAIL; TESTIS INJURY;

EID: 77955044487     PISSN: 10017844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-7844(10)60016-8     Document Type: Article

References (70)

1. Howell SJ, Shalet SM Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005, 34(1):12-17.
2. Schrader M, Muller M, Straub B, et al. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001, 15(6):611-617.
3. Udagawa K, Ogawa T, Watanabe T, et al. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int J Urol 2001, 8(11):615-622.
4. Glode LM, Robinson J, Gould SF Protection from cyclophosphamide induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1981, 1(1230):1132-1134.
5. Ward JA, Robinson J, Furr BJ, et al. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer Res 1990, 50(3):568-574.
6. Meistrich ML, Parchuri N, Wilson G, et al. Hormonal protection from cyclophosphamide-induced inactivation of rat stem spermatogonia. J Androl 1995, 16(4):334-341.
7. Meistrich ML, Wilson G, Porter KL, et al. Restoration of spermatogenesis in dibromochloropropane (DBCP)-treated rats by hormone suppression. Toxicol Sci 2003, 76(2):418-426.
8. Udagawa K, Ogawa T, Watanabe T, et al. Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats. Int J Urol 2006, 13(8):1103-1108.
9. Martindale PK The Complete Drug Reference 1999, Pharmaceutical Press, London.
10. Molenaar R, De Rooij DG, Rommerts FF, et al. Specific destruction of Leydig cells in mature rats after in vivo administration of ethane dimethyl sulfonate. Biol Reprod 1985, 33(5):1213-1222.
11. Brinster CJ, Ryu BY, Avarbock MR, et al. Restoration of fertility by germ cell transplantation requires effective recipient preparation. Biol Reprod 2003, 69(2):412-420.
12. Jiang FX Behavior of spermatogonia following recovery from busulfan treatment in the rat. Anat Embryol (Berl) 1988, 198(1):53-61.
13. Brinster CJ, Ryu BY, Avarbock MR Germline transmission of donor haplotype following spermatogonial transplantation. Proc Natl Acad Sci USA 1994, 91(24):11303-11307.
14. Moisan AE, Foster RA, Betteridge KJ, et al. Dose-response of RAG2-/-/gammac-/-mice to busulfan in preparation for spermatogonial transplantation. Reproduction 2003, 126(2):205-216.
15. Reiter RJ, Tan DX, Osuna C, et al. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000, 7(6):444-458.
16. Sanchez-hidalgo M, Delalastra CA, Carrascosa-salmoral MP, et al. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp Gerontol 2009, 44(5):328-334.
17. Velkov ZA, Velkov YZ, Galunska BT, et al. Melatonin: Quantum-chemical and biochemical investigation of antioxidant activity. Eur J Med Chem 2009, 44(7):2834-2839.
18. Ekmekcioglu C Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006, 60(3):97-108.
19. Gwayi N, Bernard RT The effects of melatonin on sperm motility in vitro in Wistar rats. Andrologia 2002, 34(6):391-396.
20. Maldonado MD, Reiter RJ, Perez-san-gregorio MA Melatonin as a potential therapeutic agent in psychiatric illness. Hum Psychopharmacol 2009, 24(5):391-400.
21. Sener G, Atasoy BM, Ersoy Y, et al. Melatonin protects against ionizing radiation-induced oxidative damage in corpus cavernosum and urinary bladder in rats. J Pineal Res 2004, 37(4):241-246.
22. Reiter RJ, Melchiori D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995, 18(1):1-11.
23. Guneli E, Tugyan K, Ozturk H, et al. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats. Eur Surg Res 2008, 40(4):354-360.
24. Bejarano I, Redondo PC, Espino J, et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009, 46(4):392-400.
25. Brinster RL Germline stem cell transplantation and transgenesis. Science 2002, 296(5576):2174-2176.
26. Lewis-Johnes DI, Kerrigan DD A modified Johnsen's count for evaluation of spermatogenesis in the rat. IRCS Med Sci 1985, 13(3):510-511.
27. Aral F, Karacal F, Baba F The effect of enrofloxacin on sperm quality in male mice. Res Vet Sci 2008, 84(1):95-99.
28. Ishikawa T, Kamodono S, Fujisawa M Fertility after h igh-dose chemotherapy for testicular can cer. Urology 2004, 63(1):137-140.
29. Howell SJ, Shalet SM Testicular function following chemotherapy. Hum Reprod Update 2001, 7(4):363-369.
30. Handelseman DJ, Peng S, Sikka S, et al. Effects of gonadotropin-releasing hormone analogs on cis-platinum-induced spermatogenic damage. Int J Androl 1988, 11(5):425-435.
31. Endo F, Manabe F, Takeshima H, et al. Protecting spermatogonia from apoptosis induced by doxorubicin using the luteinizing hormone-releasing hormone analog leuprorelin. Int J Urol 2003, 10(2):72-77.
32. Bucci LR, Meistrich ML Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat Res 1987, 176(2):259-268.
33. De Rooij DG, Russel LD All you wanted to know about spermatogonia but were afraid to ask. J Androl 2000, 21(6):776-798.
34. Shetty G, Meistrich ML Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005, (34):36-39.
35. Meistrich ML Restoration of spermatogenesis by hormone treatment after cytotoxic therapy. Acta Paediatr Scand 1999, 88(433):19-22.
36. Otubanjo AO, Mosuro A An in vivo evaluation of induction of abnormal sperm morphology by some antihelmintic drugs in mice. Mutat Res 2001, 497(1-2):131-138.
37. Wyrobek AJ, Gordon LA, Burkhart JG, et al. An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the US EPA Gene-Tox-Program. Mutat Res 1983, 115(1):1-72.
38. Adler ID Comparison of the duration of spermatogenesis between male rodents and humans. Mutat Res 1996, 352(1-2):169-172.
39. Sinha Hikim AP, Lue Y, Diaz-Romero M, et al. Deciphering the pathways of germ cell apoptosis in the testis. J Steroid Biochem Mol Biol 2003, 85(2-5):175-182.
40. Monesi V Autoradiographic study of DNA synthesis and the cell cycle in spermatogonia and spermatocytes of mouse testis using tritiated thymidine. J Cell Biol 1962, 14(1):1-18.
41. Fouchecourt S, Lareyre JJ, Chaurand P, et al. Identification, immunolocalization, regulation, and postnatal development of the lipocalin EP17 (epididymal protein of 17 kilodaltons) in the mouse and rat epididymis. Endocrinology 2003, 144(3):887-900.
42. Choi YJ, Ok DW, Kwon DN, et al. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and P53-independent manner. FEBS Lett 2004, 575(1-3):41-51.
43. Swada H, Esaki M Electron microscopic observation of 137Cs-irradiated rat testis, production of basal lamina for germ cells, despite their absence. J Electron Microscopy 2003, 52(4):391-397.
44. Sawhney P, Gimmona J, Meistrich ML, et al. Cisplatin-induced long term failure of spermatogenesis in adult c57/BL/6J Mice. J Androl 2005, 26(1):136-145.
45. Kerr JF, Wyllie AH, Currie AR Apoptosis: a basic biological ph enomenon with wide-ranging implications in tissue kinetics. Br J Cancer 2000, 26(4):239-257.
46. Sinha Hikim AP, Swerdloff RS Hormonal and genetic control of germ cell apoptosis in the testis. Rev Reprod 1999, 4(1):38-47.
47. Lee J, Richburg JH, Younkin SC, et al. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 1997, 138(5):2081-2088.
48. Ohta H, Aizawa SH, Nishimune Y Functional analysis of the p53 gene in apoptosis induced by heat stress or loss of stem cell factor signaling in mouse male germ cells. Biol Reprod 2003, 68(6):2249-2254.
49. Atessahin A, Sahna E, Turk G, et al. Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J Pineal Res 2006, 41(1):21-27.
50. Hussein MR, Abu-dief EE, Abouel-ghait AT, et al. Morphological evaluation of the radioprotective effects of melatonin against X-ray-induced early and acute testis damage in albino rats: an animal model. Int J Exp Pathol 2006, 87(3):237-250.
51. Dziegiel P, Jethon Z, Suder E, et al. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat. Exp Toxic Pathol 2002, 53(6):433-439.
52. Karaoz E, Gultekin F, Akdogan M, et al. Protective role of melatonin and a combination of vitamin C and vitamin E on lung toxicity induced by chlorpyrifos-ethyl in rats. Exp Toxic Pathol 2002, 54(2):97-108.
53. Take G, Erdogan D, Helvacioglu F, et al. Effect of melatonin and time of administration on irradiation-induced damage to rat testes. Braz J Med Biol Res 2009, 42(7):621-628.
54. Chen GH, Wang JX, Chen YQ, et al. Effect of melatonin on apoptosis of spermatogenic cells and expression of nNOS in testis of mice. J Anat (in Chinese) 2004, 27(4):383-385.
55. Mohammad Ghasemi F, Soleimani Rad J, Ghanbari AA An ultrastructural study on the apoptotic features of spermatogenic cells following busulfan treatment in adult mice. Med J Reprod Infert (in Persian) 2008, 8(4):319-329.
56. Illbey YO, Ozbek E, Simsek A, et al. Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin -induced testicu lar damage in rats. Fertil Steril 2009, 92(3):1124-1132.
57. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent, endogenous hydroxyl radicals scavenger. Endocr J 1993, 1:57-60.
58. Rastogi RK, Di Matteo L, Minucci S, et al. Regulation of rimary spermatogonial proliferation in the frog (Rana esculenta): an experimental analysis. J Zool London 1990, 220(2):201-211.
59. Minucci S, Di Matteo L, Fasano S, et al. Intratesticular control of spermatogenesis in the frog, Rana esculenta. J Exp Zool 1992, 264(1):113-118.
60. Sorrentino V, McKinney MD, Giorgi M, et al. Expression of cellular protooncogenes in the mouse male germ line: a distinctive 2,4-kb pim-1 transcript is expressed in haploid post meiotic cells. Proc Nati Acad Sci USA 1988, 85(7):2191-2195.
61. Minucci S, Di Matteo L, Pierantoni R, et al. In vivo and in vitro stimulatory effect of a gonadotropin-releasing hormone analog (HOE 766) on spermatogonial multiplication in the frog, Rana esculenta. Endocrinology 1986, 119(2):731-736.
62. Di Matteo L, Minucci S, Fasano S, et al. A gonadotropin-releasing hormone (GnRH) antagonist decreases androgen production and spermatogonial multiplication in frog (Rana esculenta): indirect evidence for the existence of GnRH or GnRHlike material receptors in the hypophysis and testis. Endocrinology 1988, 122(1):62-67.
63. Li H, Papadopoulos V, Vidic B, et al. Regulation of rat testis gonocyte proliferation by platelet-derived growth factor and estradiol: identification of signaling mechanisms involved. Endocrinology 1997, 138(3):1289-1298.
64. Cobellis G, Pierantoni R, Minucci S, et al. C-fos activity in Rana esculenta testis: seasonal and estradiol-induced changes. Endocrinology 1999, 140(7):3238-3244.
65. Hill SM, Blask DE Effects of the pineal gland hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988, 48(21):6121-6126.
66. Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995, 71(4):854-856.
67. Hermann R, Podhajsky S, Jungnickel S, et al. Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: possible involvement of mitogen-activated protein kinase and induction of apoptosis. J Pineal Res 2002, 33(1):8-13.
68. Karasek M, Liberski P, Kunert-Radek J, et al. Influence of melatonin on the proliferation of hepatoma cells in the Syrian hamster: in vivo and in vitro study. J Pineal Res 1992, 13(3):107-110.
69. Ozdemir F, Deniz O, Kaynar K, et al. The effects of melatonin on human hepatoma (Hep G2) cell line. Bratisl Lek Listy 2009, 110(5):276-279.
70. Valenti S, Giusti M, Guido R, et al. Melatonin receptors are present in adult rat Leydig cells and are coupled through a pertussis toxin-sensitive G-protein. Eur J Endocrinol 1997, 136(6):633-639.